Furey John 4
4 · Spark Therapeutics, Inc. · Filed Apr 16, 2018
Insider Transaction Report
Form 4
Furey John
Chief Operating Officer
Transactions
- Sale
Common Stock
2018-04-12$77.51/sh−20,000$1,550,200→ 0 total - Exercise/Conversion
Common Stock
2018-04-12$49.74/sh+20,000$994,800→ 20,000 total - Exercise/Conversion
Employee Stock Option (right to buy)
2018-04-12−20,000→ 140,000 totalExercise: $49.74Exp: 2026-11-30→ Common Stock (20,000 underlying)
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $77.50 to $77.56, inclusive. The reporting person undertakes to provide to Spark Therapeutics, Inc., any security holder of Spark Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4.
- [F2]25% vests December 1, 2017 and the remainder vests in equal quarterly installments over the following three years following December 1, 2017.